Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
Experimental infection and protection against ... - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
22 Chapter 1<br />
References<br />
1. World Malaria Report, 2011. (http://www.who.int/malaria)<br />
2. Gallup JL, Sachs JD. The economic burden of malaria. Am J Trop Med Hyg 2001;<br />
64:85-96.<br />
3. Desai M, ter Kuile FO, Nosten F et al. Epidemiology <strong>and</strong> burden of malaria in<br />
pregnancy. Lancet Infect Dis 2007; 7:93-104.<br />
4. Fauci AS, Braunwald E, Kasper DL et al. Harrison's Internal Medicine. 17 ed.<br />
2008.<br />
5. Millennium Development Goals, 2012. (www.un.org/millenniumgoals)<br />
6. WHO guidelines for the treatment of malaria, 2011.<br />
(http://www.who.int/malaria/publications/atoz/9789241547925/en/index.htm<br />
l)<br />
7. Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH.<br />
From malaria control to eradication: The WHO perspective. Trop Med Int Health<br />
2009; 14:802-809.<br />
8. World Malaria Report, 2011. (http://www.who.int/malaria)<br />
9. Alonso PL, Brown G, Arevalo-Herrera M et al. A research agenda to underpin<br />
malaria eradication. PLoS Med 2011; 8:e1000406.<br />
10. Malaria Vaccine Technology Roadmap, 2006.<br />
(http://www.malariavaccine.org/files/Malaria_Vaccine_TRM_Final_000.pdf)<br />
11. Crompton PD, Pierce SK, Miller LH. Advances <strong>and</strong> challenges in malaria vaccine<br />
development. J Clin Invest 2010; 120:4168-4178.<br />
12. Sauerwein RW, Roestenberg M, Moorthy VS. <strong>Experimental</strong> human challenge<br />
<strong>infection</strong>s can accelerate clinical malaria vaccine development. Nat Rev<br />
Immunol 2011; 11:57-64.<br />
13. Greenwood BM, Targett GA. Malaria vaccines <strong>and</strong> the new malaria agenda. Clin<br />
Microbiol Infect 2011; 17:1600-1607.<br />
14. Wang R, Doolan DL, Le TP et al. Induction of antigen-specific cytotoxic T<br />
lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282:476-480.<br />
15. Hill AV, Reyes-S<strong>and</strong>oval A, O'Hara G et al. Prime-boost vectored malaria<br />
vaccines: progress <strong>and</strong> prospects. Hum Vaccin 2010; 6:78-83.<br />
16. WHO Malaria Vaccine Rainbow Table, 2011.<br />
(http://www.who.int/vaccine_research/links/Rainbow/en/index.html)<br />
17. Mazier D, Goma J, Pied S et al. Hepatic phase of malaria: a crucial role as "gobetween"<br />
with other stages. Bull World Health Organ 1990; 68 Suppl:126-131.<br />
18. Krzych U, Lyon JA, Jareed T et al. T lymphocytes from volunteers immunized<br />
with irradiated Plasmodium falciparum sporozoites recognize liver <strong>and</strong> blood<br />
stage malaria antigens. J Immunol 1995; 155:4072-4077.<br />
19. Belnoue E, Voza T, Costa FT et al. Vaccination with live Plasmodium yoelii blood<br />
stage parasites under chloroquine cover induces cross-stage immunity <strong>against</strong><br />
malaria liver stage. J Immunol 2008; 181:8552-8558.